Despite some success in treating patients with Hodgkin lymphoma, many patients suffer from late effects of radiation therapy and chemotherapy treatment, including the possible onset of breast cancer or heart disease.

A study by the University of Florida Proton Therapy Institute shows that the use of proton therapy following chemotherapy in patients with Hodgkin lymphoma has a success rate similar to the conventional treatments with a reduction of radiation outside of the target area, or “involved-node”, potentially reducing the risk of late effects caused by radiation.

READ FULL ARTICLE Curated publisher From Medical News Today